The US FDA has approved the experimental antibiotic Zerbaxa for the treatment of typical urinary tract infections and intra abdominal infections. The experimental antibiotic Zerbaxa is a product by Cubist Pharmaceuticals Inc. The Federal regulators on Friday approved a new antibiotic which will fight intra-abdominal and urinary tract infections. The antibiotic is being developed by […]